Primary |
Basal Cell Carcinoma |
28.9% |
Product Used For Unknown Indication |
10.7% |
Hypertension |
10.0% |
Prophylaxis |
5.1% |
Constipation |
4.2% |
Pain |
4.0% |
Diabetes Mellitus |
3.8% |
Pancreatic Carcinoma Metastatic |
3.6% |
Nausea |
3.3% |
Depression |
3.1% |
Hypothyroidism |
2.9% |
Head And Neck Cancer |
2.7% |
Pancreatic Carcinoma |
2.7% |
Small Cell Lung Cancer |
2.7% |
Neoplasm Malignant |
2.4% |
Chondrosarcoma |
2.2% |
Anaemia |
2.0% |
Muscle Spasms |
2.0% |
Small Cell Lung Cancer Stage Unspecified |
2.0% |
Hypersensitivity |
1.8% |
|
Gamma-glutamyltransferase Increased |
8.9% |
Hepatitis |
8.0% |
Hepatotoxicity |
6.3% |
Thrombosis |
6.3% |
Death |
5.4% |
Hepatic Enzyme Increased |
5.4% |
Hyponatraemia |
5.4% |
Infection |
5.4% |
Syncope |
5.4% |
Alanine Aminotransferase Increased |
4.5% |
Angioedema |
4.5% |
Aspartate Aminotransferase Increased |
4.5% |
Disease Progression |
4.5% |
Hypoglycaemia |
4.5% |
Weight Decreased |
4.5% |
Cerebrovascular Accident |
3.6% |
Cytolytic Hepatitis |
3.6% |
Loss Of Consciousness |
3.6% |
Pyrexia |
3.6% |
Anaemia |
2.7% |
|
Secondary |
Basal Cell Carcinoma |
20.8% |
Product Used For Unknown Indication |
18.8% |
Adenocarcinoma Pancreas |
9.7% |
Metastatic Malignant Melanoma |
6.3% |
Small Cell Lung Cancer Extensive Stage |
4.2% |
Small Cell Lung Cancer Stage Unspecified |
4.2% |
Depression |
3.5% |
Hypothyroidism |
3.5% |
Medulloblastoma |
3.5% |
Chondrosarcoma |
2.8% |
Gastric Cancer |
2.8% |
Gastrooesophageal Cancer |
2.8% |
Headache |
2.8% |
Anxiety |
2.1% |
Dyspepsia |
2.1% |
Enuresis |
2.1% |
Epilepsy |
2.1% |
Hypocholesterolaemia |
2.1% |
Inflammation |
2.1% |
Nausea |
2.1% |
|
Weight Decreased |
13.0% |
Hepatotoxicity |
10.9% |
Infection |
10.9% |
Alanine Aminotransferase Increased |
6.5% |
Angioedema |
6.5% |
Aspartate Aminotransferase Increased |
6.5% |
Gamma-glutamyltransferase Increased |
6.5% |
Death |
4.3% |
Insomnia |
4.3% |
Localised Infection |
4.3% |
Perinephric Abscess |
4.3% |
Pulmonary Embolism |
4.3% |
Atrial Fibrillation |
2.2% |
Back Pain |
2.2% |
Cerebrovascular Accident |
2.2% |
Hepatic Enzyme Increased |
2.2% |
Incisional Hernia |
2.2% |
Incorrect Dose Administered |
2.2% |
Lung Neoplasm Malignant |
2.2% |
Meningitis Aseptic |
2.2% |
|
Concomitant |
Hysterectomy |
33.3% |
Hypertension |
22.2% |
Basal Cell Carcinoma |
11.1% |
Dry Skin |
11.1% |
Hyperthyroidism |
11.1% |
Thrombosis |
11.1% |
|
|